Hospira, Inc. (NYSE:HSP)

kevday (99.07) Submitted: 5/20/2013 11:58:57 AM : Start Price: $35.99 HSP Score: -0.76

Michael Price pick

http://www.marketfolly.com/2013/05/michael-prices-presentation-at-london.html

browndovecapital (43.23) Submitted: 1/7/2012 9:43:16 PM : Start Price: $30.36 HSP Score: -13.08

dddd

bradford86 (99.69) Submitted: 1/7/2012 9:37:46 PM : Start Price: $30.36 HSP Score: -13.08

233. Hospira Inc. (NYSE: HSP) is cheap after it got murdered down from the $50's. With EPS guidance of $2.95 ballpark, this is a P/E of around 11 at present. Target: $35-$40. I think that we saw some end of year tax loss selling and that's all in the past. Clear the way for higher prices. I'm voting on this with CAPS points.

http://beta.fool.com/bradford86/2012/01/07/price-market-part-32/

monkey222 (< 20) Submitted: 12/2/2011 8:22:04 AM : Start Price: $27.99 HSP Score: -4.97

Acqusition target

latinoeconomist (28.20) Submitted: 8/1/2011 3:27:29 AM : Start Price: $51.43 HSP Score: -57.84

High growth potential.

crubenst (27.58) Submitted: 5/27/2010 11:10:01 AM : Start Price: $51.17 HSP Score: -82.08

Love their new aquisition of Javelin pharmaceuticals

dreese1 (59.76) Submitted: 2/24/2009 11:48:12 AM : Start Price: $24.98 HSP Score: -81.20

Not 100% sure of the solidity of this company. Still, it is healthcare and is likely to grow...

traderpat9 (75.32) Submitted: 12/31/2008 1:11:23 PM : Start Price: $26.79 HSP Score: -54.48

HOSPIRA-AN ABBOTT SPINOFF/GOING TO CONTINUE TO GROW DURING GOOD TIMES OR BAD

blackpower68 (39.43) Submitted: 11/15/2008 10:28:21 AM : Start Price: $29.69 HSP Score: -77.67

The economy may go up or down but clinics and hospital will need the supply room stocked.Also where is the CLOROX?

phatinvestor007 (93.23) Submitted: 10/18/2008 11:47:28 AM : Start Price: $29.77 HSP Score: -59.35

Cheaper drugs are needed

APMary (< 20) Submitted: 9/22/2008 9:19:02 AM : Start Price: $38.29 HSP Score: +44.11

1:13

zdocisin (< 20) Submitted: 4/22/2008 5:31:19 PM : Start Price: $40.90 HSP Score: +38.31

Will get caught up in its own hype, and get swallowed up by not feeding its infrastructure

qasamm (71.23) Submitted: 2/13/2008 6:21:21 PM : Start Price: $41.61 HSP Score: -41.12

With the recall of Baxter's Heprin and a scramble for hospitals to find a replacement HSP has the oportunity to fill the void and grab a big chunk of the market.

Sales should increase with this new demand.

ashishdwivedi (63.36) Submitted: 11/26/2007 11:36:41 PM : Start Price: $42.08 HSP Score: -38.46

Posted positive Earnings surprise recently. Good earning history.

DrStan (51.13) Submitted: 3/13/2007 4:10:08 PM : Start Price: $39.28 HSP Score: +37.05

I owned this stock when it split from Abbott and sold it at a profit. There are too many good competitors lined up against it.

heinfr (57.95) Submitted: 10/11/2006 12:14:57 PM : Start Price: $37.27 HSP Score: +35.77

hopsital care commodities is a tough business right now.